LB Pharmaceuticals
No bio yet
This person is not in the org chart
This person is not in any teams
This person is not in any offices
LB Pharmaceuticals
1 followers
LB Pharmaceuticals is a drug development company focused on development treatments for CNS disorders. The company's lead compound is LB-102; a novel benzamide being developed the treatment of schizophrenia owned and development internally by LB. LB-102 recently completed a Phase 1 study; a First-in-patient study is planned for July 2021.